 |
Medication Safety Officers Society 3680 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations |
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
Hello all,
We are reviewing a request to add Exparel to formulary at our pediatric hospital. There are 2 main concerns we have with this medication: 1. Cannot administer a local anesthetic for 96 hrs after Exparel administration due to toxicity, 2. Looks like propofol but cannot be given IV so concern for wrong route error and harm.
If your institution has Exparel on formulary, what mitigations do you have in place to prevent these errors from reaching the patient?
Thank you in advance!